Drug recall · January 6, 2021
Ketorolac Tromethamine Injection recall
Why: Presence of Particulate Matter - found in reserve sample vials at the firm.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), packaged in 2 mL Single Dose Vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-162-02
- Lots / codes
Batch # 6121125, Exp 02/2021
- Quantity
- 490,633 vials
- Company
- Fresenius Kabi USA, LLC, Lake Zurich, IL
- Distribution
- USA Nationwide and Puerto Rico
- Initiated
- December 17, 2020 · Voluntary: Firm initiated
- Classified
- December 31, 2020
- Reported
- January 6, 2021
- Ended
- June 20, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ketorolac
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.